Litron Laboratories

Litron Laboratories is a long-established, privately held company operating at the intersection of diagnostics, genetics, and genomics within the toxicology sector. Its core business revolves around proprietary flow cytometry assay kits (e.g., MicroFlow, MutaFlow, MultiFlow) and complementary scoring services for detecting DNA damage and mutations, primarily serving pharmaceutical, medical device, government, and contract research organizations globally. The company differentiates itself through deep scientific expertise, continuous innovation in assay development, and a strong commitment to providing unlimited, personalized technical support directly from its method developers. With a mission to protect human health, Litron has built a reputation as a critical partner for regulatory safety testing over its 40-year history.

Proprietary flow cytometry-based assay kits and analysis methods for detecting DNA damage (micronuclei) and gene mutations (Pig-a), including multiplexed biomarker assessment (MultiFlow).

Litron competes in the specialized genetic toxicology testing market against other assay kit providers, CROs offering similar testing services, and manual microscopy-based methods. Its primary competitive advantage is its deep scientific expertise, proprietary flow-cytometry methods, and direct technical support from its developers, though it faces potential competition from larger instrument and reagent conglomerates.